The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -78.75% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -62.36%. Over the past 30 days, the price of CHRO has fallen by 15.76%. And in the last five days, it has surged by 17.12%.
52-week price history of CHRO Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Chromocell Therapeutics Corp.’s current trading price is -83.00% away from its 52-week high, while its distance from the 52-week low is 74.36%. The stock’s price range during this time has been between $0.58 and $6.00. The trading volume for the Healthcare sector company’s shares reached about 0.94 million for the day, which was higher than the average daily volume of 27110.0 over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization vs. Financial Performance: A Comparative Study
Chromocell Therapeutics Corp. (CHRO) has experienced a quarterly decline of -24.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.89M and boasts a workforce of 8 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2026, with a change in price of -0.7501. Similarly, Chromocell Therapeutics Corp. recorded 38,071 in trading volume during the last 100 days, posting a change of -42.38%.
CHRO Stock Stochastic Average
Today’s raw stochastic average for Chromocell Therapeutics Corp. over the last 50 days is 49.15%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 80.43%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 49.50% and 42.92%, respectively.
